Vera Imper
Vermogen: 250 055 $ op 31-05-2026
Vermogen: 250 055 $ op 31-05-2026
Dr. Vera Imper is an Independent Director at Cytek Biosciences, Inc. She is on the Board of Directors at Cytek Biosciences, Inc. Dr. Imper was previously employed as a Vice President & Head-Business Development by Roche Molecular Solutions and a Vice President-Worldwide Business Development by BD Biosciences Clontech.
She received her undergraduate degree from the University of Zagreb, a graduate degree from the University of Zagreb and a doctorate degree from the University of Zagreb.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 59.679 ( 0,05% ) | 250 055 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Directeur/Bestuurslid | 31-12-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Corporate Officer/Principal | 01-10-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Health Technology |
University of Zagreb
University of Zagreb Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytek Biosciences, Inc.
Cytek Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a life sciences technology company engages in the provision of cell analysis tools by leveraging novel technical approaches | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau